Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Suk Hyung Lee(Columbia University Irving Medical Center), Wenhuo Hu(Memorial Sloan Kettering Cancer Center), Justin T. Matulay(NewYork–Presbyterian Hospital), Mark V. Silva(NewYork–Presbyterian Hospital), Tomasz B. Owczarek(Columbia University Irving Medical Center), Kwanghee Kim(Memorial Sloan Kettering Cancer Center), Chee Wai Chua(Columbia University Irving Medical Center), LaMont J. Barlow(NewYork–Presbyterian Hospital), Cyriac Kandoth(Memorial Sloan Kettering Cancer Center), Alanna B. Williams(Columbia University Irving Medical Center), Sarah K. Bergren(Columbia University Irving Medical Center), Eugene J. Pietzak(Memorial Sloan Kettering Cancer Center), Christopher B. Anderson(NewYork–Presbyterian Hospital), Mitchell C. Benson(NewYork–Presbyterian Hospital), Jonathan Coleman(Memorial Sloan Kettering Cancer Center), Barry S. Taylor(Memorial Sloan Kettering Cancer Center), Cory Abate‐Shen(Columbia University Irving Medical Center), James M. McKiernan(NewYork–Presbyterian Hospital), Hikmat Al‐Ahmadie(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center), Michael M. Shen(Columbia University Irving Medical Center)
Cell
April 1, 2018
10.1016/j.cell.2018.03.017
Cited by 866Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis